AR and prostate cancer: In situ Hi-C maps confirm that the enhancer–promoter interactions are more frequently detected in 22Rv1 prostate cancer cells than in RWPE1 normal cells; there are also cancer-specific smaller-size TADs near the AR gene (Fig. 6a).